The company is hoping longer follow-up will deliver enough positive trial data on its CRISPR T-cell therapies for blood ...

Crispr Therapeutics is an emerging gene editing company focused on the development of Crispr/Cas9-based therapeutics. The company's proprietary platform specializes in clustered regularly interspaced ...

The Global Cell And Gene Therapy Market is valued at USD 20.5 Billion in 2024 and is projected to reach a value of USD 128.8 ...

Strategic pipeline prioritization with workforce and cost reductions expected to extend the company's cash runway by one year into H2 2027 -- -- Two robust clinical datasets from CB-010 and CB-011 ...

Strategic pipeline prioritization with workforce and cost reductions expected to extend the company’s cash runway by one year into H2 2027 -- -- Two robust clinical datasets from CB-010 and CB-011 now ...

Pfizer (NYSE:PFE) is a global pharmaceutical giant that has long been a cornerstone of medical innovation and today boasts a ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

Developments in genomics are enabling the rise of personalised medicine, with therapies tailored specifically for individuals ...

Dr Olwyn Mahon on how she uses 3D models to understand tumour behaviour in urological cancers and why translating lab work to ...

Biotech firms are engineering smarter, safer gene delivery systems to enhance the safety and efficacy of genetic medicines.

Caribou is scaling back its operations, halting multiple programmes, and cutting staff to focus on two cancer programmes.

Plant breeding plays a vital role in ensuring global food security by increasing crop yields, improving nutritional quality ...